Chikungunya immunisation
RecruitingStudy on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion
Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion
- Disease:Chikungunya immunisation
- Substances:Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated
France- Participants:18–64 years
- Substances:Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated
- Sponsor:Centre Hospitalier Universitaire De La Reunion

